scispace - formally typeset
Open AccessJournal Article

Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.

TLDR
Hydroxylation of C-7 in delta6-THC does not alter inhibitory potency, but its oxidation to an acid and aromatization of ring A greatly reduce affinity, which is critical for inhibition of NE, 5-HT and GABA uptake.
Abstract
We have examined the effect of Delta1-tetrahydrocannabinol (delat1-THC) and 12 of its derivatives on the uptake of 3H-labeled norepinephrine (NE), dopamine (DA), serotonin (5-HT) gamma-aminobutyric acid (GABA) into synaptosomes in homogenates of various regions of rat brain. Delta1-THC inhibits the accumulation of NE and 5-HT into hypothalamic preparations and DA into the corpus striatum with Ki values of about 12 to 25 muM while GABA uptake into cerebral cortical preparations is inhibited less (Ki = 140 muM). The affinities of delta6-THC, 7-hydroxy-delta1-THC, 7-hydroxy-delta6-THC and cannabidiol for 5-HT, NE and GABA transports are similar to values for delta1-THC, while cannabigerol, cannabinol and delta6-THC-7-oic acid have substantially less affinity. Thus, hydroxylation of C-7 in delta6-THC does not alter inhibitory potency, but its oxidation to an acid and aromatization of ring A greatly reduce affinity. The hydroxyl at C-3(1) of ring C is critical for inhibition of NE, 5-HT and GABA uptake, since its acetylation or methylation abolishes activity. Inhibition of NE, DA, 5-HT and GABA uptake by all cannabinoids examined is noncompetitive. Only about 1% of delta1-THC and delta6-THC and 5% of cannabidiol are fully soluble under our experimental conditions.

read more

Citations
More filters
Journal ArticleDOI

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.

TL;DR: Pretreatment with flurazepam or chlordiazepoxide markedly enhanced the cataleptic response of mice to delta-9-tetrahydrocannabinol (THC) and it is possible that THC interacts with benzodiazepines by increasing synaptic concentrations of gamma-aminobutyric acid (GABA).
Journal ArticleDOI

Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia

TL;DR: Overall, these findings show that CBD can restore cannabinoid/GABAergic signalling deficits in regions of the brain implicated in schizophrenia pathophysiology following maternal poly I:C exposure, and provide novel evidence for the potential mechanisms underlying the therapeutic effects of CBD treatment in the poly I-C model.
Journal ArticleDOI

Effects of SR141716A on Diazepam Substitution for Δ9-Tetrahydrocannabinol in Rat Drug Discrimination

TL;DR: The results suggest that the partial overlap in the discriminative stimulus effects of delta9-THC and diazepam is not mediated by diazepAM action at CB1 receptors, and is consistent with a GABAergic component to cannabinoid drug discrimination.
Journal ArticleDOI

Environmental stress as a factor in the response of rat brain catecholamine metabolism to Δ8-tetrahydrocannabinol

TL;DR: It is suggested that some of the behavioural effects of cannabis administered under stressful conditions may be related to alterations in striatal dopamine metabolism, which is consistent with increased dopamine reuptake in striatum produced by this combination of THC and novel environment.
Journal ArticleDOI

Prolactin Suppression by (-) Δ-9-Tetrahydrocannabinol (THC): Involvement of Serotonergic and Dopaminergic Pathways

TL;DR: It seems that THC also enhances the dopaminergic activity in the pathway that controls PRL secretion, and is suggested on involvement of a serotonergic pathway in the suppressive effect of THC onPRL secretion.
Related Papers (5)
Trending Questions (1)
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum

The paper does not mention the inhibition of adenosine uptake by cannabinoids. It only mentions the inhibition of dopamine uptake in the corpus striatum.